In Wyoming, what can make a substance prescription-only?

In Wyoming, the classification of a substance as prescription-only is influenced by new scientific evidence or public petitions submitted to the Board of Pharmacy (BOP). This mechanism allows for the dynamic assessment of substances based on current research and community health needs. The incorporation of new scientific data provides the foundation for re-evaluating a substance's safety and efficacy, influencing its status and ensuring that regulatory decisions reflect the latest understanding of a substance's impact on public health.

Public petitions also play a significant role, as they enable stakeholders, including healthcare professionals and community members, to express concerns or advocate for changes based on emerging evidence. The combination of scientific evidence and public input helps ensure that decisions regarding prescription status are made transparently and in the best interest of patient care and safety.

The other options do not align with the regulatory framework governing prescription-only statuses. While local health boards and national compendiums hold value, they do not have the direct authority to classify substances as prescription-only without the considerations outlined above. States rights do set the stage for substance classifications, but specific actions and evidence as defined by Wyoming law are critical for making a substance prescription-only.